Exane Derivatives’s Meta Platforms (Facebook) META Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-155
Closed -$465 959
2020
Q4
$465 Sell
155
-141
-48% -$38.7K ﹤0.01% 745
2020
Q3
$17.9K Buy
296
+40
+16% +$10.3K 0.01% 447
2020
Q2
$70.9K Buy
256
+216
+540% +$45.1K 0.02% 329
2020
Q1
$60K Buy
+40
New +$7.83K 0.02% 342
2017
Q1
Sell
-200
Closed -$1.8K 622
2016
Q4
$1.8K Hold
200
﹤0.01% 452
2016
Q3
$9.8K Buy
+200
New +$24.8K ﹤0.01% 403
2016
Q2
Sell
-200
Closed -$102K 600
2016
Q1
$102K Sell
200
-150
-43% -$15.8K 0.01% 241
2015
Q4
$182K Buy
350
+200
+133% +$20.5K 0.02% 166
2015
Q3
$41.7K Hold
150
0.01% 284
2015
Q2
$50.2K Buy
+150
New +$12.2K 0.01% 287

Other funds holding META

Exane Derivatives's META Position: Q2 2022 in Review

Exane Derivatives increased its Meta Platforms (Facebook) (META) stake by 20% in Q2 2022, buying an estimated $274K and bringing the position to 8,517 shares worth $1.37M. The position accounts for 0.79% of the portfolio, ranked #28.

Exane Derivatives first reported a position in META in Q4 2014 and has held it in 23 quarters since. The position peaked at $20.4M in Q4 2015. 3,074 funds tracked by Wall St. Rank hold META as of Q2 2022.

  • Exane Derivatives held 8,517 shares of Meta Platforms (Facebook) worth $1.37M as of Q2 2022.
  • Exane Derivatives bought 1,420 Meta Platforms (Facebook) shares in Q2 2022, an estimated $274K.
  • Meta Platforms (Facebook) made up 0.79% of Exane Derivatives's portfolio in Q2 2022, its #28 holding.
  • Exane Derivatives first reported a position in Meta Platforms (Facebook) in Q4 2014 and has held it in 23 quarters since.
  • Exane Derivatives's Meta Platforms (Facebook) position peaked at $20.4M in Q4 2015.
  • 3,074 funds tracked by Wall St. Rank held Meta Platforms (Facebook) as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.